Skip to content
OpenCapital
Get started

Vera Therapeutics VERA Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$1.69Miss by $0.36
Revenue estimate$426.0K
EPS estimate-$1.33

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$1.3M
EPS estimate-$1.60

Financials

Q1 2026

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$2.53B+89.7%
Enterprise value$2.49B+82.9%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Versus estimates

Diluted EPS

Q1 2026-$1.69Miss by $0.36
Q4 2025-$1.39Miss by $0.05Q3 2025-$1.26Miss by $0.06Q2 2025-$1.20Miss by $0.38Q1 2025-$0.81Miss by $0.06Q4 2024-$0.72Beat by $0.11

Ask the moment Vera Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Vera Therapeutics report Q1 2026 earnings?
Vera Therapeutics (VERA) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Vera Therapeutics's Q1 2026 revenue and EPS?
Vera Therapeutics reported eps of $-1.69 for Q1 2026.
Did Vera Therapeutics beat estimates in Q1 2026?
EPS missed the consensus estimate of $-1.33 by $0.36.
How did Vera Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 108.6% from $-0.81.
Where can I find Vera Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-210351) and the 10-Q periodic report (0001193125-26-212143) directly on SEC EDGAR. The filing index links above go to sec.gov.